APO Research, Inc.
Talk to an analyst

APO RESEARCH · REPORT

Chronic Disease Treatment

Compare research editions
View pricing & licenses

Selected research

Market Outlook & Growth Opportunities

Global Chronic Disease Treatment Market Outlook and Growth Opportunities 2026

Report ID 17409010041 May 2026196 pages

Choose your research edition.

Industry ResearchChronic Disease Treatment Industry Research Report 2026117 pages · $2,950 USDIndustry Growth & TrendsGlobal Chronic Disease Treatment Industry Growth and Trends Forecast to 2032102 pages · $3,450 USDMarket StructureGlobal Chronic Disease Treatment Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032196 pages · $3,950 USDMarket Outlook & Growth OpportunitiesGlobal Chronic Disease Treatment Market Outlook and Growth Opportunities 2026196 pages · $4,250 USDMarket Analysis & ForecastGlobal Chronic Disease Treatment Market Analysis and Forecast 2026-2032255 pages · $4,950 USD

Market perspective

The global Chronic Disease Treatment market was valued at US$ million in 2026 and is projected to reach US$ million by 2032, implying a compound annual growth rate (CAGR) of % over 2026-2032.

The North America market for Chronic Disease Treatment is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

The Europe market for Chronic Disease Treatment is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

Read the full market overview

The Asia Pacific market for Chronic Disease Treatment is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

In China, the Chronic Disease Treatment market is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

Major global companies in the Chronic Disease Treatment market include PrecisionLife, Novo Nordisk, Becton Dickinson, Apollo TeleHealth, Sidekick Health, AstraZeneca, Biofourmis, S3 Connected Health and MindMaze, among others. In 2025, the top three vendors together accounted for approximately % of global market revenue.

This report provides an overview of the global Chronic Disease Treatment market in terms of revenue and gross margin, analyzing global market trends using historical revenue data for 2021-2025, estimates for 2026, and projected CAGRs through 2032.

The study covers key producers of Chronic Disease Treatment and market revenue by major regions and countries, assesses future market potential, and highlights priority regions and countries for segmenting the market into sub-sectors, with country-specific market value data for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, the Middle East, Africa, and other countries.

The report also presents Chronic Disease Treatment revenue, market share, and industry ranking for the main companies for 2021-2026, identifies the major stakeholders in the global market, and analyzes their competitive landscape and market positioning based on recent developments and segmental revenues.

Across the 2021-2026 period, the analysis compares revenue growth and profitability profiles by company, distinguishing participants with sustained expansion from those with more cyclical performance, and relates these patterns to differences in regional exposure, product portfolios, and application focus in the global Chronic Disease Treatment market.

Chronic Disease Treatment Segment by Company

PrecisionLife

Novo Nordisk

Becton Dickinson

Apollo TeleHealth

Sidekick Health

AstraZeneca

Biofourmis

S3 Connected Health

MindMaze

CSL Vifor

Aetna Better Health

Vancouver Coastal Health

Diathrive Health

Chronic Disease Treatment Segment by Type

Medical Treatement

Physiotherapy

Surgical Treatment

Others

Chronic Disease Treatment Segment by Application

Chronic Respiratory Disease

Chronic Cardiovascular Disease

Chronic Digestive Diseases

Chronic Urinary Tract Disease

Endocrine System Diseases

Others

Chronic Disease Treatment Segment by Region

North America

United States

Canada

Mexico

Europe

Germany

France

U.K.

Italy

Russia

Spain

Netherlands

Switzerland

Sweden

Poland

Asia-Pacific

China

Japan

South Korea

India

Australia

Taiwan

Southeast Asia

South America

Brazil

Argentina

Chile

Middle East & Africa

Egypt

South Africa

Israel

Türkiye

GCC Countries

Study Objectives

1. To analyze and research the global Chronic Disease Treatment status and future forecast, involving, revenue, growth rate (CAGR), market share, historical and forecast.

2. To present the Chronic Disease Treatment key companies, revenue, market share, and recent developments.

3. To split the Chronic Disease Treatment breakdown data by regions, type, companies, and application.

4. To analyze the global and key regions Chronic Disease Treatment market potential and advantage, opportunity and challenge, restraints, and risks.

5. To identify Chronic Disease Treatment significant trends, drivers, influence factors in global and regions.

6. To analyze Chronic Disease Treatment competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.

Reasons to Buy This Report

1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Chronic Disease Treatment market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.

2. This report will help stakeholders to understand the global industry status and trends of Chronic Disease Treatment and provides them with information on key market drivers, restraints, challenges, and opportunities.

3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in sales and value), competitor ecosystem, new product development, expansion, and acquisition.

4. This report stays updated with novel technology integration, features, and the latest developments in the market.

5. This report helps stakeholders to gain insights into which regions to target globally.

6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Chronic Disease Treatment.

7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.

Chapter Outline

Chapter 1: Introduces the report scope of the report, global total market size.

Chapter 2: Analysis key trends, drivers, challenges, and opportunities within the global Chronic Disease Treatment industry.

Chapter 3: Detailed analysis of Chronic Disease Treatment company competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.

Chapter 4: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.

Chapter 5: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.

Chapter 6: Sales value of Chronic Disease Treatment in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the market development, future development prospects, market space, and market size of key country in the world.

Chapter 7: Sales value of Chronic Disease Treatment in country level. It provides sigmate data by type, and by application for each country/region.

Chapter 8: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including revenue, gross margin, product introduction, recent development, etc.

Chapter 9: Concluding Insights.

More report detail

Tables and figures
List of Tables Table 1. Chronic Disease Treatment Industry Trends Table 2. Chronic Disease Treatment Industry Drivers Table 3. Chronic Disease Treatment Industry Opportunities and Challenges Table 4. Chronic Disease Treatment Industry Restraints Table 5. Global Chronic Disease Treatment Revenue by Company (US$ Million) & (2021-2026) Table 6. Global Chronic Disease Treatment Revenue Share by Company (2021-2026) Table 7. Global Chronic Disease Treatment Company Ranking, (2024-2026) & (US$ Million) Table 8. Global Chronic Disease Treatment Key Company Manufacturing Base & Headquarters Table 9. Global Chronic Disease Treatment Company, Product Type & Application Table 10. Global Chronic Disease Treatment Company Establishment Date Table 11. Global Company Market Concentration Ratio (CR5 and HHI) Table 12. Global Chronic Disease Treatment by Company Type (Tier 1, Tier 2, and Tier 3) & (Based on Revenue of 2025) Table 13. Mergers & Acquisitions, Expansion Table 14. Significant Companies of Medical Treatement Table 15. Significant Companies of Physiotherapy Table 16. Significant Companies of Surgical Treatment Table 17. Significant Companies of Others Table 18. Global Chronic Disease Treatment Sales Value by Type 2021 VS 2025 VS 2032 (US$ Million) Table 19. Global Chronic Disease Treatment Sales Value by Type (2021-2026) & (US$ Million) Table 20. Global Chronic Disease Treatment Sales Value by Type (2027-2032) & (US$ Million) Table 21. Global Chronic Disease Treatment Sales Value Share by Type (2021-2026) Table 22. Global Chronic Disease Treatment Sales Value Share by Type (2027-2032) Table 23. Significant Companies of Chronic Respiratory Disease Table 24. Significant Companies of Chronic Cardiovascular Disease Table 25. Significant Companies of Chronic Digestive Diseases Table 26. Significant Companies of Chronic Urinary Tract Disease Table 27. Significant Companies of Endocrine System Diseases Table 28. Significant Companies of Others Table 29. Global Chronic Disease Treatment Sales Value by Application 2021 VS 2025 VS 2032 (US$ Million) Table 30. Global Chronic Disease Treatment Sales Value by Application (2021-2026) & (US$ Million) Table 31. Global Chronic Disease Treatment Sales Value by Application (2027-2032) & (US$ Million) Table 32. Global Chronic Disease Treatment Sales Value Share by Application (2021-2026) Table 33. Global Chronic Disease Treatment Sales Value Share by Application (2027-2032) Table 34. Global Chronic Disease Treatment Sales Value Comparison by Region: 2021 VS 2025 VS 2032 (US$ Million) Table 35. Global Chronic Disease Treatment Sales Value by Region (2021-2026) & (US$ Million) Table 36. Global Chronic Disease Treatment Sales Value Share by Region (2021-2026) Table 37. Global Chronic Disease Treatment Sales Value by Region (2027-2032) & (US$ Million) Table 38. Global Chronic Disease Treatment Sales Value Share by Region (2027-2032) Table 39. Global Chronic Disease Treatment Sales Value by Country: 2021 VS 2025 VS 2032 (US$ Million) Table 40. Global Chronic Disease Treatment Sales Value by Country (2021-2026) & (US$ Million) Table 41. Global Chronic Disease Treatment Sales Value Market Share by Country (2021-2026) Table 42. Global Chronic Disease Treatment Sales Value by Country (2027-2032) & (US$ Million) Table 43. Global Chronic Disease Treatment Sales Value Market Share by Country (2027-2032) Table 44. PrecisionLife Company Information Table 45. PrecisionLife Business Overview Table 46. PrecisionLife Chronic Disease Treatment Revenue (US$ Million) and Gross Margin (2021-2026) Table 47. PrecisionLife Chronic Disease Treatment Product Portfolio Table 48. PrecisionLife Recent Development Table 49. Novo Nordisk Company Information Table 50. Novo Nordisk Business Overview Table 51. Novo Nordisk Chronic Disease Treatment Revenue (US$ Million) and Gross Margin (2021-2026) Table 52. Novo Nordisk Chronic Disease Treatment Product Portfolio Table 53. Novo Nordisk Recent Development Table 54. Becton Dickinson Company Information Table 55. Becton Dickinson Business Overview Table 56. Becton Dickinson Chronic Disease Treatment Revenue (US$ Million) and Gross Margin (2021-2026) Table 57. Becton Dickinson Chronic Disease Treatment Product Portfolio Table 58. Becton Dickinson Recent Development Table 59. Apollo TeleHealth Company Information Table 60. Apollo TeleHealth Business Overview Table 61. Apollo TeleHealth Chronic Disease Treatment Revenue (US$ Million) and Gross Margin (2021-2026) Table 62. Apollo TeleHealth Chronic Disease Treatment Product Portfolio Table 63. Apollo TeleHealth Recent Development Table 64. Sidekick Health Company Information Table 65. Sidekick Health Business Overview Table 66. Sidekick Health Chronic Disease Treatment Revenue (US$ Million) and Gross Margin (2021-2026) Table 67. Sidekick Health Chronic Disease Treatment Product Portfolio Table 68. Sidekick Health Recent Development Table 69. AstraZeneca Company Information Table 70. AstraZeneca Business Overview Table 71. AstraZeneca Chronic Disease Treatment Revenue (US$ Million) and Gross Margin (2021-2026) Table 72. AstraZeneca Chronic Disease Treatment Product Portfolio Table 73. AstraZeneca Recent Development Table 74. Biofourmis Company Information Table 75. Biofourmis Business Overview Table 76. Biofourmis Chronic Disease Treatment Revenue (US$ Million) and Gross Margin (2021-2026) Table 77. Biofourmis Chronic Disease Treatment Product Portfolio Table 78. Biofourmis Recent Development Table 79. S3 Connected Health Company Information Table 80. S3 Connected Health Business Overview Table 81. S3 Connected Health Chronic Disease Treatment Revenue (US$ Million) and Gross Margin (2021-2026) Table 82. S3 Connected Health Chronic Disease Treatment Product Portfolio Table 83. S3 Connected Health Recent Development Table 84. MindMaze Company Information Table 85. MindMaze Business Overview Table 86. MindMaze Chronic Disease Treatment Revenue (US$ Million) and Gross Margin (2021-2026) Table 87. MindMaze Chronic Disease Treatment Product Portfolio Table 88. MindMaze Recent Development Table 89. CSL Vifor Company Information Table 90. CSL Vifor Business Overview Table 91. CSL Vifor Chronic Disease Treatment Revenue (US$ Million) and Gross Margin (2021-2026) Table 92. CSL Vifor Chronic Disease Treatment Product Portfolio Table 93. CSL Vifor Recent Development Table 94. Aetna Better Health Company Information Table 95. Aetna Better Health Business Overview Table 96. Aetna Better Health Chronic Disease Treatment Sales (k units), Value (US$ Million), Price (USD/unit) and Gross Margin (2021-2026) Table 97. Aetna Better Health Chronic Disease Treatment Product Portfolio Table 98. Aetna Better Health Recent Development Table 99. Vancouver Coastal Health Company Information Table 100. Vancouver Coastal Health Business Overview Table 101. Vancouver Coastal Health Chronic Disease Treatment Sales (k units), Value (US$ Million), Price (USD/unit) and Gross Margin (2021-2026) Table 102. Vancouver Coastal Health Chronic Disease Treatment Product Portfolio Table 103. Vancouver Coastal Health Recent Development Table 104. Diathrive Health Company Information Table 105. Diathrive Health Business Overview Table 106. Diathrive Health Chronic Disease Treatment Sales (k units), Value (US$ Million), Price (USD/unit) and Gross Margin (2021-2026) Table 107. Diathrive Health Chronic Disease Treatment Product Portfolio Table 108. Diathrive Health Recent Development Table 109. Research Programs/Design for This Report Table 110. Authors List of This Report Table 111. Secondary Sources Table 112. Primary Sources List of Figures Figure 1. Chronic Disease Treatment Product Image Figure 2. Global Chronic Disease Treatment Market Size (US$ Million), 2021 VS 2025 VS 2032 Figure 3. Global Chronic Disease Treatment Market Size (2021-2032) & (US$ Million) Figure 4. Global Chronic Disease Treatment Company Revenue Ranking in 2025 (US$ Million) Figure 5. Global Top 5 and 10 Company Market Share by Revenue in 2025 (US$ Million) Figure 6. Company Type (Tier 1, Tier 2, and Tier 3): 2021 VS 2025 Figure 7. Medical Treatement Image Figure 8. Physiotherapy Image Figure 9. Surgical Treatment Image Figure 10. Others Image Figure 11. Global Chronic Disease Treatment Sales Value by Type (2021 VS 2025 VS 2032) & (US$ Million) Figure 12. Global Chronic Disease Treatment Sales Value Share 2021 VS 2025 VS 2032 Figure 13. Global Chronic Disease Treatment Sales Value Share by Type (2021-2032) Figure 14. Chronic Respiratory Disease Image Figure 15. Chronic Cardiovascular Disease Image Figure 16. Chronic Digestive Diseases Image Figure 17. Chronic Urinary Tract Disease Image Figure 18. Endocrine System Diseases Image Figure 19. Others Image Figure 20. Global Chronic Disease Treatment Sales Value by Application (2021 VS 2025 VS 2032) & (US$ Million) Figure 21. Global Chronic Disease Treatment Sales Value Share 2021 VS 2025 VS 2032 Figure 22. Global Chronic Disease Treatment Sales Value Share by Application (2021-2032) Figure 23. Global Chronic Disease Treatment Sales Value Comparison by Region: 2021 VS 2025 VS 2032 (US$ Million) Figure 24. Global Chronic Disease Treatment Sales Value Share by Region: 2021 VS 2025 VS 2032 Figure 25. North America Chronic Disease Treatment Sales Value (2021-2032) & (US$ Million) Figure 26. North America Chronic Disease Treatment Sales Value Share by Country (%), 2025 VS 2032 Figure 27. Europe Chronic Disease Treatment Sales Value (2021-2032) & (US$ Million) Figure 28. Europe Chronic Disease Treatment Sales Value Share by Country (%), 2025 VS 2032 Figure 29. Asia-Pacific Chronic Disease Treatment Sales Value (2021-2032) & (US$ Million) Figure 30. Asia-Pacific Chronic Disease Treatment Sales Value Share by Country (%), 2025 VS 2032 Figure 31. South America Chronic Disease Treatment Sales Value (2021-2032) & (US$ Million) Figure 32. South America Chronic Disease Treatment Sales Value Share by Country (%), 2025 VS 2032 Figure 33. Middle East & Africa Chronic Disease Treatment Sales Value (2021-2032) & (US$ Million) Figure 34. Middle East & Africa Chronic Disease Treatment Sales Value Share by Country (%), 2025 VS 2032 Figure 35. USA Chronic Disease Treatment Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 36. USA Chronic Disease Treatment Sales Value Share by Type, 2025 VS 2032 & (%) Figure 37. USA Chronic Disease Treatment Sales Value Share by Application, 2025 VS 2032 & (%) Figure 38. Canada Chronic Disease Treatment Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 39. Canada Chronic Disease Treatment Sales Value Share by Type, 2025 VS 2032 & (%) Figure 40. Canada Chronic Disease Treatment Sales Value Share by Application, 2025 VS 2032 & (%) Figure 41. Mexico Chronic Disease Treatment Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 42. Mexico Chronic Disease Treatment Sales Value Share by Type, 2025 VS 2032 & (%) Figure 43. Mexico Chronic Disease Treatment Sales Value Share by Application, 2025 VS 2032 & (%) Figure 44. Germany Chronic Disease Treatment Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 45. Germany Chronic Disease Treatment Sales Value Share by Type, 2025 VS 2032 & (%) Figure 46. Germany Chronic Disease Treatment Sales Value Share by Application, 2025 VS 2032 & (%) Figure 47. France Chronic Disease Treatment Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 48. France Chronic Disease Treatment Sales Value Share by Type, 2025 VS 2032 & (%) Figure 49. France Chronic Disease Treatment Sales Value Share by Application, 2025 VS 2032 & (%) Figure 50. U.K. Chronic Disease Treatment Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 51. U.K. Chronic Disease Treatment Sales Value Share by Type, 2025 VS 2032 & (%) Figure 52. U.K. Chronic Disease Treatment Sales Value Share by Application, 2025 VS 2032 & (%) Figure 53. Italy Chronic Disease Treatment Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 54. Italy Chronic Disease Treatment Sales Value Share by Type, 2025 VS 2032 & (%) Figure 55. Italy Chronic Disease Treatment Sales Value Share by Application, 2025 VS 2032 & (%) Figure 56. Spain Chronic Disease Treatment Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 57. Spain Chronic Disease Treatment Sales Value Share by Type, 2025 VS 2032 & (%) Figure 58. Spain Chronic Disease Treatment Sales Value Share by Application, 2025 VS 2032 & (%) Figure 59. Russia Chronic Disease Treatment Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 60. Russia Chronic Disease Treatment Sales Value Share by Type, 2025 VS 2032 & (%) Figure 61. Russia Chronic Disease Treatment Sales Value Share by Application, 2025 VS 2032 & (%) Figure 62. Netherlands Chronic Disease Treatment Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 63. Netherlands Chronic Disease Treatment Sales Value Share by Type, 2025 VS 2032 & (%) Figure 64. Netherlands Chronic Disease Treatment Sales Value Share by Application, 2025 VS 2032 & (%) Figure 65. Nordic Countries Chronic Disease Treatment Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 66. Nordic Countries Chronic Disease Treatment Sales Value Share by Type, 2025 VS 2032 & (%) Figure 67. Nordic Countries Chronic Disease Treatment Sales Value Share by Application, 2025 VS 2032 & (%) Figure 68. China Chronic Disease Treatment Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 69. China Chronic Disease Treatment Sales Value Share by Type, 2025 VS 2032 & (%) Figure 70. China Chronic Disease Treatment Sales Value Share by Application, 2025 VS 2032 & (%) Figure 71. Japan Chronic Disease Treatment Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 72. Japan Chronic Disease Treatment Sales Value Share by Type, 2025 VS 2032 & (%) Figure 73. Japan Chronic Disease Treatment Sales Value Share by Application, 2025 VS 2032 & (%) Figure 74. South Korea Chronic Disease Treatment Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 75. South Korea Chronic Disease Treatment Sales Value Share by Type, 2025 VS 2032 & (%) Figure 76. South Korea Chronic Disease Treatment Sales Value Share by Application, 2025 VS 2032 & (%) Figure 77. India Chronic Disease Treatment Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 78. India Chronic Disease Treatment Sales Value Share by Type, 2025 VS 2032 & (%) Figure 79. India Chronic Disease Treatment Sales Value Share by Application, 2025 VS 2032 & (%) Figure 80. Australia Chronic Disease Treatment Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 81. Australia Chronic Disease Treatment Sales Value Share by Type, 2025 VS 2032 & (%) Figure 82. Australia Chronic Disease Treatment Sales Value Share by Application, 2025 VS 2032 & (%) Figure 83. Southeast Asia Chronic Disease Treatment Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 84. Southeast Asia Chronic Disease Treatment Sales Value Share by Type, 2025 VS 2032 & (%) Figure 85. Southeast Asia Chronic Disease Treatment Sales Value Share by Application, 2025 VS 2032 & (%) Figure 86. Brazil Chronic Disease Treatment Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 87. Brazil Chronic Disease Treatment Sales Value Share by Type, 2025 VS 2032 & (%) Figure 88. Brazil Chronic Disease Treatment Sales Value Share by Application, 2025 VS 2032 & (%) Figure 89. Argentina Chronic Disease Treatment Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 90. Argentina Chronic Disease Treatment Sales Value Share by Type, 2025 VS 2032 & (%) Figure 91. Argentina Chronic Disease Treatment Sales Value Share by Application, 2025 VS 2032 & (%) Figure 92. Chile Chronic Disease Treatment Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 93. Chile Chronic Disease Treatment Sales Value Share by Type, 2025 VS 2032 & (%) Figure 94. Chile Chronic Disease Treatment Sales Value Share by Application, 2025 VS 2032 & (%) Figure 95. Colombia Chronic Disease Treatment Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 96. Colombia Chronic Disease Treatment Sales Value Share by Type, 2025 VS 2032 & (%) Figure 97. Colombia Chronic Disease Treatment Sales Value Share by Application, 2025 VS 2032 & (%) Figure 98. Peru Chronic Disease Treatment Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 99. Peru Chronic Disease Treatment Sales Value Share by Type, 2025 VS 2032 & (%) Figure 100. Peru Chronic Disease Treatment Sales Value Share by Application, 2025 VS 2032 & (%) Figure 101. Saudi Arabia Chronic Disease Treatment Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 102. Saudi Arabia Chronic Disease Treatment Sales Value Share by Type, 2025 VS 2032 & (%) Figure 103. Saudi Arabia Chronic Disease Treatment Sales Value Share by Application, 2025 VS 2032 & (%) Figure 104. Israel Chronic Disease Treatment Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 105. Israel Chronic Disease Treatment Sales Value Share by Type, 2025 VS 2032 & (%) Figure 106. Israel Chronic Disease Treatment Sales Value Share by Application, 2025 VS 2032 & (%) Figure 107. UAE Chronic Disease Treatment Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 108. UAE Chronic Disease Treatment Sales Value Share by Type, 2025 VS 2032 & (%) Figure 109. UAE Chronic Disease Treatment Sales Value Share by Application, 2025 VS 2032 & (%) Figure 110. Turkey Chronic Disease Treatment Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 111. Turkey Chronic Disease Treatment Sales Value Share by Type, 2025 VS 2032 & (%) Figure 112. Turkey Chronic Disease Treatment Sales Value Share by Application, 2025 VS 2032 & (%) Figure 113. Iran Chronic Disease Treatment Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 114. Iran Chronic Disease Treatment Sales Value Share by Type, 2025 VS 2032 & (%) Figure 115. Iran Chronic Disease Treatment Sales Value Share by Application, 2025 VS 2032 & (%) Figure 116. Egypt Chronic Disease Treatment Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 117. Egypt Chronic Disease Treatment Sales Value Share by Type, 2025 VS 2032 & (%) Figure 118. Egypt Chronic Disease Treatment Sales Value Share by Application, 2025 VS 2032 & (%) Figure 119. Years Considered Figure 120. Research Process Figure 121. Key Executives Interviewed

Scope & coverage.

Types
  • Medical Treatement
  • Physiotherapy
  • Surgical Treatment
  • Others
Applications
  • Chronic Respiratory Disease
  • Chronic Cardiovascular Disease
  • Chronic Digestive Diseases
  • Chronic Urinary Tract Disease
  • Endocrine System Diseases
  • Others
Companies covered
  • PrecisionLife
  • Novo Nordisk
  • Becton Dickinson
  • Apollo TeleHealth
  • Sidekick Health
  • AstraZeneca
  • Biofourmis
  • S3 Connected Health
  • MindMaze
  • CSL Vifor
  • Aetna Better Health
  • Vancouver Coastal Health
  • Diathrive Health

Inside the report.

1 Market Overview
  1. 1.1 Product Definition
  2. 1.2 Global Chronic Disease Treatment Market Size, 2021 VS 2025 VS 2032
  3. 1.3 Global Chronic Disease Treatment Market Size (2021-2032)
  4. 1.4 Assumptions and Limitations
  5. 1.5 Study Goals and Objectives
2 Chronic Disease Treatment Market Dynamics
  1. 2.1 Chronic Disease Treatment Industry Trends
  2. 2.2 Chronic Disease Treatment Industry Drivers
  3. 2.3 Chronic Disease Treatment Industry Opportunities and Challenges
  4. 2.4 Chronic Disease Treatment Industry Restraints
3 Chronic Disease Treatment Market by Company
  1. 3.1 Global Chronic Disease Treatment Company Revenue Ranking in 2025
  2. 3.2 Global Chronic Disease Treatment Revenue by Company (2021-2026)
  3. 3.3 Global Chronic Disease Treatment Company Ranking (2024-2026)
  4. 3.4 Global Chronic Disease Treatment Company Manufacturing Base and Headquarters
  5. 3.5 Global Chronic Disease Treatment Company Product Type and Application
  6. 3.6 Global Chronic Disease Treatment Company Establishment Date
  7. 3.7 Market Competitive Analysis
  8. 3.7.1 Global Chronic Disease Treatment Market Concentration Ratio (CR5 and HHI)
  9. 3.7.2 Global Top 5 and 10 Company Market Share by Revenue in 2025
  10. 3.7.3 2025 Chronic Disease Treatment Tier 1, Tier 2, and Tier 3 Companies
  11. 3.8 Mergers and Acquisitions Expansion
4 Chronic Disease Treatment Market by Type
  1. 4.1 Chronic Disease Treatment Type Introduction
  2. 4.1.1 Medical Treatement
  3. 4.1.2 Physiotherapy
  4. 4.1.3 Surgical Treatment
  5. 4.1.4 Others
  6. 4.2 Global Chronic Disease Treatment Sales Value by Type
  7. 4.2.1 Global Chronic Disease Treatment Sales Value by Type (2021 VS 2025 VS 2032)
  8. 4.2.2 Global Chronic Disease Treatment Sales Value by Type (2021-2032)
  9. 4.2.3 Global Chronic Disease Treatment Sales Value Share by Type (2021-2032)
5 Chronic Disease Treatment Market by Application
  1. 5.1 Chronic Disease Treatment Application Introduction
  2. 5.1.1 Chronic Respiratory Disease
  3. 5.1.2 Chronic Cardiovascular Disease
  4. 5.1.3 Chronic Digestive Diseases
  5. 5.1.4 Chronic Urinary Tract Disease
  6. 5.1.5 Endocrine System Diseases
  7. 5.1.6 Others
  8. 5.2 Global Chronic Disease Treatment Sales Value by Application
  9. 5.2.1 Global Chronic Disease Treatment Sales Value by Application (2021 VS 2025 VS 2032)
  10. 5.2.2 Global Chronic Disease Treatment Sales Value by Application (2021-2032)
  11. 5.2.3 Global Chronic Disease Treatment Sales Value Share by Application (2021-2032)
6 Chronic Disease Treatment Regional Value Analysis
  1. 6.1 Global Chronic Disease Treatment Sales Value by Region: 2021 VS 2025 VS 2032
  2. 6.2 Global Chronic Disease Treatment Sales Value by Region (2021-2032)
  3. 6.2.1 Global Chronic Disease Treatment Sales Value by Region: 2021-2026
  4. 6.2.2 Global Chronic Disease Treatment Sales Value by Region (2027-2032)
  5. 6.3 North America
  6. 6.3.1 North America Chronic Disease Treatment Sales Value (2021-2032)
  7. 6.3.2 North America Chronic Disease Treatment Sales Value Share by Country, 2025 VS 2032
  8. 6.4 Europe
  9. 6.4.1 Europe Chronic Disease Treatment Sales Value (2021-2032)
  10. 6.4.2 Europe Chronic Disease Treatment Sales Value Share by Country, 2025 VS 2032
  11. 6.5 Asia-Pacific
  12. 6.5.1 Asia-Pacific Chronic Disease Treatment Sales Value (2021-2032)
  13. 6.5.2 Asia-Pacific Chronic Disease Treatment Sales Value Share by Country, 2025 VS 2032
  14. 6.6 South America
  15. 6.6.1 South America Chronic Disease Treatment Sales Value (2021-2032)
  16. 6.6.2 South America Chronic Disease Treatment Sales Value Share by Country, 2025 VS 2032
  17. 6.7 Middle East & Africa
  18. 6.7.1 Middle East & Africa Chronic Disease Treatment Sales Value (2021-2032)
  19. 6.7.2 Middle East & Africa Chronic Disease Treatment Sales Value Share by Country, 2025 VS 2032
7 Chronic Disease Treatment Country-level Value Analysis
  1. 7.1 Global Chronic Disease Treatment Sales Value by Country: 2021 VS 2025 VS 2032
  2. 7.2 Global Chronic Disease Treatment Sales Value by Country (2021-2032)
  3. 7.2.1 Global Chronic Disease Treatment Sales Value by Country (2021-2026)
  4. 7.2.2 Global Chronic Disease Treatment Sales Value by Country (2027-2032)
  5. 7.3 USA
  6. 7.3.1 USA Chronic Disease Treatment Sales Value Growth Rate (2021-2032)
  7. 7.3.2 USA Chronic Disease Treatment Sales Value Share by Type, 2025 VS 2032
  8. 7.3.3 USA Chronic Disease Treatment Sales Value Share by Application, 2025 VS 2032
  9. 7.4 Canada
  10. 7.4.1 Canada Chronic Disease Treatment Sales Value Growth Rate (2021-2032)
  11. 7.4.2 Canada Chronic Disease Treatment Sales Value Share by Type, 2025 VS 2032
  12. 7.4.3 Canada Chronic Disease Treatment Sales Value Share by Application, 2025 VS 2032
  13. 7.5 Mexico
  14. 7.5.1 Mexico Chronic Disease Treatment Sales Value Growth Rate (2021-2032)
  15. 7.5.2 Mexico Chronic Disease Treatment Sales Value Share by Type, 2025 VS 2032
  16. 7.5.3 Mexico Chronic Disease Treatment Sales Value Share by Application, 2025 VS 2032
  17. 7.6 Germany
  18. 7.6.1 Germany Chronic Disease Treatment Sales Value Growth Rate (2021-2032)
  19. 7.6.2 Germany Chronic Disease Treatment Sales Value Share by Type, 2025 VS 2032
  20. 7.6.3 Germany Chronic Disease Treatment Sales Value Share by Application, 2025 VS 2032
  21. 7.7 France
  22. 7.7.1 France Chronic Disease Treatment Sales Value Growth Rate (2021-2032)
  23. 7.7.2 France Chronic Disease Treatment Sales Value Share by Type, 2025 VS 2032
  24. 7.7.3 France Chronic Disease Treatment Sales Value Share by Application, 2025 VS 2032
  25. 7.8 U.K.
  26. 7.8.1 U.K. Chronic Disease Treatment Sales Value Growth Rate (2021-2032)
  27. 7.8.2 U.K. Chronic Disease Treatment Sales Value Share by Type, 2025 VS 2032
  28. 7.8.3 U.K. Chronic Disease Treatment Sales Value Share by Application, 2025 VS 2032
  29. 7.9 Italy
  30. 7.9.1 Italy Chronic Disease Treatment Sales Value Growth Rate (2021-2032)
  31. 7.9.2 Italy Chronic Disease Treatment Sales Value Share by Type, 2025 VS 2032
  32. 7.9.3 Italy Chronic Disease Treatment Sales Value Share by Application, 2025 VS 2032
  33. 7.10 Spain
  34. 7.10.1 Spain Chronic Disease Treatment Sales Value Growth Rate (2021-2032)
  35. 7.10.2 Spain Chronic Disease Treatment Sales Value Share by Type, 2025 VS 2032
  36. 7.10.3 Spain Chronic Disease Treatment Sales Value Share by Application, 2025 VS 2032
  37. 7.11 Russia
  38. 7.11.1 Russia Chronic Disease Treatment Sales Value Growth Rate (2021-2032)
  39. 7.11.2 Russia Chronic Disease Treatment Sales Value Share by Type, 2025 VS 2032
  40. 7.11.3 Russia Chronic Disease Treatment Sales Value Share by Application, 2025 VS 2032
  41. 7.12 Netherlands
  42. 7.12.1 Netherlands Chronic Disease Treatment Sales Value Growth Rate (2021-2032)
  43. 7.12.2 Netherlands Chronic Disease Treatment Sales Value Share by Type, 2025 VS 2032
  44. 7.12.3 Netherlands Chronic Disease Treatment Sales Value Share by Application, 2025 VS 2032
  45. 7.13 Nordic Countries
  46. 7.13.1 Nordic Countries Chronic Disease Treatment Sales Value Growth Rate (2021-2032)
  47. 7.13.2 Nordic Countries Chronic Disease Treatment Sales Value Share by Type, 2025 VS 2032
  48. 7.13.3 Nordic Countries Chronic Disease Treatment Sales Value Share by Application, 2025 VS 2032
  49. 7.14 China
  50. 7.14.1 China Chronic Disease Treatment Sales Value Growth Rate (2021-2032)
  51. 7.14.2 China Chronic Disease Treatment Sales Value Share by Type, 2025 VS 2032
  52. 7.14.3 China Chronic Disease Treatment Sales Value Share by Application, 2025 VS 2032
  53. 7.15 Japan
  54. 7.15.1 Japan Chronic Disease Treatment Sales Value Growth Rate (2021-2032)
  55. 7.15.2 Japan Chronic Disease Treatment Sales Value Share by Type, 2025 VS 2032
  56. 7.15.3 Japan Chronic Disease Treatment Sales Value Share by Application, 2025 VS 2032
  57. 7.16 South Korea
  58. 7.16.1 South Korea Chronic Disease Treatment Sales Value Growth Rate (2021-2032)
  59. 7.16.2 South Korea Chronic Disease Treatment Sales Value Share by Type, 2025 VS 2032
  60. 7.16.3 South Korea Chronic Disease Treatment Sales Value Share by Application, 2025 VS 2032
  61. 7.17 India
  62. 7.17.1 India Chronic Disease Treatment Sales Value Growth Rate (2021-2032)
  63. 7.17.2 India Chronic Disease Treatment Sales Value Share by Type, 2025 VS 2032
  64. 7.17.3 India Chronic Disease Treatment Sales Value Share by Application, 2025 VS 2032
  65. 7.18 Australia
  66. 7.18.1 Australia Chronic Disease Treatment Sales Value Growth Rate (2021-2032)
  67. 7.18.2 Australia Chronic Disease Treatment Sales Value Share by Type, 2025 VS 2032
  68. 7.18.3 Australia Chronic Disease Treatment Sales Value Share by Application, 2025 VS 2032
  69. 7.19 Southeast Asia
  70. 7.19.1 Southeast Asia Chronic Disease Treatment Sales Value Growth Rate (2021-2032)
  71. 7.19.2 Southeast Asia Chronic Disease Treatment Sales Value Share by Type, 2025 VS 2032
  72. 7.19.3 Southeast Asia Chronic Disease Treatment Sales Value Share by Application, 2025 VS 2032
  73. 7.20 Brazil
  74. 7.20.1 Brazil Chronic Disease Treatment Sales Value Growth Rate (2021-2032)
  75. 7.20.2 Brazil Chronic Disease Treatment Sales Value Share by Type, 2025 VS 2032
  76. 7.20.3 Brazil Chronic Disease Treatment Sales Value Share by Application, 2025 VS 2032
  77. 7.21 Argentina
  78. 7.21.1 Argentina Chronic Disease Treatment Sales Value Growth Rate (2021-2032)
  79. 7.21.2 Argentina Chronic Disease Treatment Sales Value Share by Type, 2025 VS 2032
  80. 7.21.3 Argentina Chronic Disease Treatment Sales Value Share by Application, 2025 VS 2032
  81. 7.22 Chile
  82. 7.22.1 Chile Chronic Disease Treatment Sales Value Growth Rate (2021-2032)
  83. 7.22.2 Chile Chronic Disease Treatment Sales Value Share by Type, 2025 VS 2032
  84. 7.22.3 Chile Chronic Disease Treatment Sales Value Share by Application, 2025 VS 2032
  85. 7.23 Colombia
  86. 7.23.1 Colombia Chronic Disease Treatment Sales Value Growth Rate (2021-2032)
  87. 7.23.2 Colombia Chronic Disease Treatment Sales Value Share by Type, 2025 VS 2032
  88. 7.23.3 Colombia Chronic Disease Treatment Sales Value Share by Application, 2025 VS 2032
  89. 7.24 Peru
  90. 7.24.1 Peru Chronic Disease Treatment Sales Value Growth Rate (2021-2032)
  91. 7.24.2 Peru Chronic Disease Treatment Sales Value Share by Type, 2025 VS 2032
  92. 7.24.3 Peru Chronic Disease Treatment Sales Value Share by Application, 2025 VS 2032
  93. 7.25 Saudi Arabia
  94. 7.25.1 Saudi Arabia Chronic Disease Treatment Sales Value Growth Rate (2021-2032)
  95. 7.25.2 Saudi Arabia Chronic Disease Treatment Sales Value Share by Type, 2025 VS 2032
  96. 7.25.3 Saudi Arabia Chronic Disease Treatment Sales Value Share by Application, 2025 VS 2032
  97. 7.26 Israel
  98. 7.26.1 Israel Chronic Disease Treatment Sales Value Growth Rate (2021-2032)
  99. 7.26.2 Israel Chronic Disease Treatment Sales Value Share by Type, 2025 VS 2032
  100. 7.26.3 Israel Chronic Disease Treatment Sales Value Share by Application, 2025 VS 2032
  101. 7.27 UAE
  102. 7.27.1 UAE Chronic Disease Treatment Sales Value Growth Rate (2021-2032)
  103. 7.27.2 UAE Chronic Disease Treatment Sales Value Share by Type, 2025 VS 2032
  104. 7.27.3 UAE Chronic Disease Treatment Sales Value Share by Application, 2025 VS 2032
  105. 7.28 Turkey
  106. 7.28.1 Turkey Chronic Disease Treatment Sales Value Growth Rate (2021-2032)
  107. 7.28.2 Turkey Chronic Disease Treatment Sales Value Share by Type, 2025 VS 2032
  108. 7.28.3 Turkey Chronic Disease Treatment Sales Value Share by Application, 2025 VS 2032
  109. 7.29 Iran
  110. 7.29.1 Iran Chronic Disease Treatment Sales Value Growth Rate (2021-2032)
  111. 7.29.2 Iran Chronic Disease Treatment Sales Value Share by Type, 2025 VS 2032
  112. 7.29.3 Iran Chronic Disease Treatment Sales Value Share by Application, 2025 VS 2032
  113. 7.30 Egypt
  114. 7.30.1 Egypt Chronic Disease Treatment Sales Value Growth Rate (2021-2032)
  115. 7.30.2 Egypt Chronic Disease Treatment Sales Value Share by Type, 2025 VS 2032
  116. 7.30.3 Egypt Chronic Disease Treatment Sales Value Share by Application, 2025 VS 2032
8 Company Profiles
  1. 8.1 PrecisionLife
  2. 8.1.1 PrecisionLife Company Information
  3. 8.1.2 PrecisionLife Business Overview
  4. 8.1.3 PrecisionLife Chronic Disease Treatment Revenue and Gross Margin (2021-2026)
  5. 8.1.4 PrecisionLife Chronic Disease Treatment Product Portfolio
  6. 8.1.5 PrecisionLife Recent Developments
  7. 8.2 Novo Nordisk
  8. 8.2.1 Novo Nordisk Company Information
  9. 8.2.2 Novo Nordisk Business Overview
  10. 8.2.3 Novo Nordisk Chronic Disease Treatment Revenue and Gross Margin (2021-2026)
  11. 8.2.4 Novo Nordisk Chronic Disease Treatment Product Portfolio
  12. 8.2.5 Novo Nordisk Recent Developments
  13. 8.3 Becton Dickinson
  14. 8.3.1 Becton Dickinson Company Information
  15. 8.3.2 Becton Dickinson Business Overview
  16. 8.3.3 Becton Dickinson Chronic Disease Treatment Revenue and Gross Margin (2021-2026)
  17. 8.3.4 Becton Dickinson Chronic Disease Treatment Product Portfolio
  18. 8.3.5 Becton Dickinson Recent Developments
  19. 8.4 Apollo TeleHealth
  20. 8.4.1 Apollo TeleHealth Company Information
  21. 8.4.2 Apollo TeleHealth Business Overview
  22. 8.4.3 Apollo TeleHealth Chronic Disease Treatment Revenue and Gross Margin (2021-2026)
  23. 8.4.4 Apollo TeleHealth Chronic Disease Treatment Product Portfolio
  24. 8.4.5 Apollo TeleHealth Recent Developments
  25. 8.5 Sidekick Health
  26. 8.5.1 Sidekick Health Company Information
  27. 8.5.2 Sidekick Health Business Overview
  28. 8.5.3 Sidekick Health Chronic Disease Treatment Revenue and Gross Margin (2021-2026)
  29. 8.5.4 Sidekick Health Chronic Disease Treatment Product Portfolio
  30. 8.5.5 Sidekick Health Recent Developments
  31. 8.6 AstraZeneca
  32. 8.6.1 AstraZeneca Company Information
  33. 8.6.2 AstraZeneca Business Overview
  34. 8.6.3 AstraZeneca Chronic Disease Treatment Revenue and Gross Margin (2021-2026)
  35. 8.6.4 AstraZeneca Chronic Disease Treatment Product Portfolio
  36. 8.6.5 AstraZeneca Recent Developments
  37. 8.7 Biofourmis
  38. 8.7.1 Biofourmis Company Information
  39. 8.7.2 Biofourmis Business Overview
  40. 8.7.3 Biofourmis Chronic Disease Treatment Revenue and Gross Margin (2021-2026)
  41. 8.7.4 Biofourmis Chronic Disease Treatment Product Portfolio
  42. 8.7.5 Biofourmis Recent Developments
  43. 8.8 S3 Connected Health
  44. 8.8.1 S3 Connected Health Company Information
  45. 8.8.2 S3 Connected Health Business Overview
  46. 8.8.3 S3 Connected Health Chronic Disease Treatment Revenue and Gross Margin (2021-2026)
  47. 8.8.4 S3 Connected Health Chronic Disease Treatment Product Portfolio
  48. 8.8.5 S3 Connected Health Recent Developments
  49. 8.9 MindMaze
  50. 8.9.1 MindMaze Company Information
  51. 8.9.2 MindMaze Business Overview
  52. 8.9.3 MindMaze Chronic Disease Treatment Revenue and Gross Margin (2021-2026)
  53. 8.9.4 MindMaze Chronic Disease Treatment Product Portfolio
  54. 8.9.5 MindMaze Recent Developments
  55. 8.10 CSL Vifor
  56. 8.10.1 CSL Vifor Company Information
  57. 8.10.2 CSL Vifor Business Overview
  58. 8.10.3 CSL Vifor Chronic Disease Treatment Revenue and Gross Margin (2021-2026)
  59. 8.10.4 CSL Vifor Chronic Disease Treatment Product Portfolio
  60. 8.10.5 CSL Vifor Recent Developments
  61. 8.11 Aetna Better Health
  62. 8.11.1 Aetna Better Health Company Information
  63. 8.11.2 Aetna Better Health Business Overview
  64. 8.11.3 Aetna Better Health Chronic Disease Treatment Revenue and Gross Margin (2021-2026)
  65. 8.11.4 Aetna Better Health Chronic Disease Treatment Product Portfolio
  66. 8.11.5 Aetna Better Health Recent Developments
  67. 8.12 Vancouver Coastal Health
  68. 8.12.1 Vancouver Coastal Health Company Information
  69. 8.12.2 Vancouver Coastal Health Business Overview
  70. 8.12.3 Vancouver Coastal Health Chronic Disease Treatment Revenue and Gross Margin (2021-2026)
  71. 8.12.4 Vancouver Coastal Health Chronic Disease Treatment Product Portfolio
  72. 8.12.5 Vancouver Coastal Health Recent Developments
  73. 8.13 Diathrive Health
  74. 8.13.1 Diathrive Health Company Information
  75. 8.13.2 Diathrive Health Business Overview
  76. 8.13.3 Diathrive Health Chronic Disease Treatment Revenue and Gross Margin (2021-2026)
  77. 8.13.4 Diathrive Health Chronic Disease Treatment Product Portfolio
  78. 8.13.5 Diathrive Health Recent Developments
9 Concluding Insights
    10 Appendix
    1. 10.1 Reasons for Doing This Study
    2. 10.2 Research Methodology
    3. 10.3 Research Process
    4. 10.4 Authors List of This Report
    5. 10.5 Data Source
    6. 10.5.1 Secondary Sources
    7. 10.5.2 Primary Sources

    GET THE RESEARCH

    Choose your license.

    Choose who needs access.
    All options are for this report and research series.

    Compare access permissions.

    Single User License
    One named user. Individual access.
    Multi User License
    Up to 5 users in the same department.
    Enterprise License
    Organization-wide access within the agreed license.

    Access applies to the purchased edition. Later editions are separate purchases.

    License options
    $4,250USD
    Buy now

    PDF by email within 3–5 working days after payment confirmation.

    Talk to an analyst
    APO Research, Inc.
    Talk to an analyst